Gene Query: EML4

Dataset Description Geneva Score
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 69.44
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 46.76
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 35.75
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 35.75
ZIKV infection of monocytes activates inflammasome pathways 35.7
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 34.7
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 34.61
Transcriptomic analysis of human tonsillar TFH subsets 31.88
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 30.38
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 29.32
Single-nucleotide-resolution mapping of HBV promoters using CAGE 28.4
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 27.45
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 26.28
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 24.88
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  24.35
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 24.31
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 24.31
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 23.26
Transcriptional profiles of normal human mature B cells 22.35
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 22.33
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 21.44
Genes significantly down or Up-regulated upon RNF219 knockdown 20.72
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 20.63
Differential analysis of gene regulation at transcript resolution by RNA-Seq 20.62
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 20.62
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 20.37
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 20.36
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 20.34
RNAseq analysis of ESRP regulated splicing events in prostate cancer 19.52
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 19.41
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 19.25
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 19.11
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 19.0
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 18.7
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 18.54
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 18.5
RNA-seq of young and quiescent MRC-5 human fibroblasts 18.4
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 17.78
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 17.78
Unique features and clinical importance of acute alloreactive immune responses 17.69
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 17.66
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 17.5
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 17.49
MEIS1 regulates hematopoiesis in hPSCs 17.14
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 16.78
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 16.67
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 16.63
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 16.59
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 16.55
Transcriptome wide analysis of classically and alternatively activated macrophages 16.5
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 16.48
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 16.48
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 16.42
RNAseq Analysis in glioblastoma cells treated with Mepazine 16.4
Transcriptomic analyssis following EHMT1/2 inhibition 16.29
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 16.21
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 15.97
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 15.75
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 15.75
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 15.66
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 15.49
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 15.17
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 15.13
Differentially expressed vascular development genes for iPSC-ECs from CDI 15.1
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 14.99
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 14.99
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 14.97
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 14.9
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 14.87
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 14.87
mRNA expression in human DAOY cells 14.75
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 14.71
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 14.7
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 14.69
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 14.69
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 14.41
Transcriptome of Stabilin-1 siRNA transfected human monocytes 14.34
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 14.32
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 14.21
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 14.14
High level DNA repair gene expression in human ES cells 13.99
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 13.97
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 13.89
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 13.89
High-throughput sequencing of PROMPT-enriched samples. 13.75
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 13.74
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 13.71
Depicting early human development and germ cell origin with porcine embryos 13.7
Gene expression profiling of KSHV-infected periodontal ligament cells 13.68
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 13.68
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 13.56
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 13.56
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 13.47
Irf9 function in immunity in mouse 13.4
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 13.4
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 13.36
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 13.31
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 12.81
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 12.79
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 12.78
AMPK signaling for naïve pluripotency [Hs] 12.74
AMPK signaling for naïve pluripotency 12.74
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 12.72
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 12.72
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 12.45
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 12.44
Neurofibroma 12.44
Trans-differentiation of human adult peripheral blood T cells into neurons 12.37
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 12.35
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 12.34
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 12.27
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 12.26
Global analyses of the effect of different cellular contexts on microRNA targeting 12.25
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 12.25
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 12.16
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 12.15
A549 cells and MSR-A549 cells 12.07
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 12.07
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 12.06
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 12.02
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 11.99
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 11.83
RNA expression analysis upon JMJD1C depletion 11.83
Short and Long RNA sequencing of human mature erythrocytes 11.82
Genome-wide functional assessment of enhancer activities in the human genome 11.79
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 11.79
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 11.79
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 11.72
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 11.72
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 11.56
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 11.54
MYCL and EP400 are required for Max and MCPyV mediated gene activation 11.53
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 11.52
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 11.44
Expression profiling of etoposide-induced senescent cells 11.42
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 11.39
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 11.39
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 11.37
Expression data from miR340 overexpressing human A549 cells 11.26
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 11.2
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 11.17
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 11.05
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 10.98
EGR1-controlled transcriptome of T HESCs 10.98
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 10.92
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 10.92
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 10.9
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 10.84
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 10.84
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 10.78
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 10.75
RNA-seq of YB5 cells treated with Proscillaridin A 10.71
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 10.63
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 10.61
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 10.6
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 10.49
Differentially expressed genes post knock down of lincDUSP26 10.43
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 10.42
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 10.4
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 10.32
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 10.24
IMP3 regulated gene expression in breast cancer cells 10.17
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 10.13
Regulation of highly expressed hCINAP on translatome 10.1
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 10.09
A transcriptome-wide divergence in protein translation scales with LIN28B expression 10.09
The cohesin release factor WAPL restricts chromatin loop extension. 9.95
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 9.95
Changes in human endometrial gland transcriptome over the window of implantation 9.9
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 9.88
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 9.81
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 9.8
TGF-β promotes genomic instability after loss of RUNX3 9.79
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 9.69
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 9.65
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 9.62
MYC dependent mRNA translation shapes gene expression and cell biology 9.59
3’ Uridylation Expands miRNA Target Repertoire 9.58
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 9.58
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 9.58
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 9.53
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 9.49
An RNA-centric dissection of host complexes controlling flavivirus infection 9.49
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 9.49
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 9.47
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 9.45
Reassessment of Exosome Composition 9.35
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 9.33
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 9.29
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 9.28
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 9.27
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 9.22
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 9.22
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 9.21
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 9.21
Co-transcriptional loading of RNA export factors shapes the human transcriptome 9.18
RNAseq of HEK293 cells after Chtop knockdown 9.18
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 9.13
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 9.13
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 9.08
Integrating single-cell transcriptomic data across different conditions, technologies, and species 9.03
Global Mapping of Human RNA-RNA Interactions 9.02
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 8.96
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 8.96
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 8.96
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 8.91
Global response to chemotherapy-induced apoptosis 8.91
BCL11B 8.89
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 8.88
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 8.87
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 8.87
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 8.86
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 8.86
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 8.85
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 8.78
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 8.72
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 8.7
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 8.7
Sensing self and nonself circular RNAs 8.68
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 8.66
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 8.58
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 8.58
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 8.58
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 8.54
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 8.53
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 8.53
RNA-sequencing in irradiated and normal A549 cells. 8.47
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 8.46
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 8.46
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 8.42
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 8.4
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 8.4
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 8.38
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 8.37
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 8.34
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 8.34
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 8.24
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 8.21
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 8.17
Molecular Criteria for Defining the Naive Human Pluripotent State 8.15
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 8.11
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 8.1
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 8.08
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 8.06
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 8.06
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 8.06
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.06
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 8.05
Effect of from Human Umbilical Vein Endothelial Cells 7.98
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 7.94
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 7.94
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 7.93
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 7.93
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 7.9
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 7.85
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 7.85
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 7.83
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 7.8
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 7.67
Human cell line and subcutaneous tumor 7.61
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 7.59
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 7.54
The cytokine environment influence on human skin-derived T cells 7.53
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 7.46
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 7.46
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 7.45
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 7.42
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 7.27
Defective structural RNA processing in relapsing-remitting multiple sclerosis 7.25
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 7.23
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 7.2
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 7.18
miR941 overexpression experiment 7.08
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 6.95
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 6.9
RNA-sequencing 6.86
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 6.85
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 6.83
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 6.77
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 6.72
Ro60-knockout cells 6.67
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 6.67
RNA-seq of naive and primed ES cells 6.64
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 6.6
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 6.54
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 6.52
Determination of tRNA aminoacylation levels by high throughput sequencing 6.48
CD86 regulates a pro-survival signal in myeloma cells 6.46
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 6.36
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 6.36
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 6.36
HEK293 TFAM Knockout Expression Study 6.35
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 6.33
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 6.33
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 6.26
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 6.15
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 6.11
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 5.99
Regulation of poly(A) tail and translation during the somatic cell cycle 5.91
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 5.87
Transcriptional landscape changes during human embryonic stem cell derivation 5.81
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 5.76
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 5.76
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 5.68
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 5.68
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 5.67
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 5.67
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 5.67
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 5.66
N6-methyladenine DNA Modification in Glioblastoma 5.62
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 5.62
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 5.62
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 5.58
CDK12 mediated transcriptional regulation in U2OS cells 5.47
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 5.43
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 5.28
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 5.27
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 5.27
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 5.26
RNA sequencing of mechanically strained NHEKs and control NHEKs 5.14
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 5.09
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 5.02
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 5.01
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 4.97
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 4.94
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 4.84
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 4.8
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 4.8
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 4.69
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 4.53
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 4.46
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 4.44
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 4.42
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 4.34
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 4.33
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 4.32
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 4.31
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 4.29
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 4.23
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 4.22
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 4.17
Human Treg NaCl stimulation 4.07
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 4.04
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 4.04
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 4.04
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 4.02
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 4.0
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 3.98
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 3.96
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 3.96
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.83
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 3.82
Exploring ILF2 regulatory genes by next-generation sequencing 3.8
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 3.8
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 3.78
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 3.76
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 3.73
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 3.72
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 3.72
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 3.69
Gene expression activation in CLL mediated by MSCs contact 3.68
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 3.67
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.65
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.65
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 3.63
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 3.62
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 3.55
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 3.52
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 3.52
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 3.52
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 3.51
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.46
CHCHD2 gene KO effect in iPSC drived motor neurons 3.45
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 3.4
RNA-seq data 3.36
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 3.33
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 3.33
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 3.27
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.27
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 3.12
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 3.04
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 3.02
Noncoding regions are the main source of targetable tumor-specific antigens 3.02
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 2.99
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 2.94
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 2.91
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 2.9
Measure transcript integrity using RNA-seq data 2.9
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 2.9
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 2.9
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 2.85
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.81
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.81
EWS-Fli and LNC regulated genes in comparison to GFP samples 2.71
Identification of expressed and conserved human non-coding RNAs 2.64
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 2.62
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 2.62
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.55
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 2.54
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 2.49
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 2.49
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 2.48
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 2.45
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 2.45
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.45
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 2.4
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 2.36
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.36
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.36
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 2.34
quanTIseq: quantifying immune contexture of human tumors 2.33
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.28
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.27
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.21
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 2.2
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 2.19
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 2.19
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 2.13
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 2.09
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.08
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 2.08
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.0
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.99
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.96
Hepatocyte maturation 1.96
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 1.91
Gene expression analysis in response to hypoxic pathway inhibition 1.81
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.8
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.79
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 1.78
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.77
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.77
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 1.75
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.74
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 1.72
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.71
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 1.68
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 1.62
Analyses of T-ALL (COG study) 1.56
RNA sequencing of T-ALL (COG study) 1.56
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.54
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.51
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 1.44
Human T-cell lymphoblastic lymphoma samples and control thymuses 1.44
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.42
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 1.36
Age-Related Gene Expression Changes in Prostate Cancer Patients 1.36
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.27
Alagille_Nodder 1.24
RNA Seq of Alagille liver biopsies 1.24
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 1.17
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 1.15
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 1.12
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 1.1
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 1.07
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 1.06
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 1.04
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.04
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.02
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 1.0
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.97
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.97
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 0.95
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 0.92
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 0.92
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 0.92
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.88
Human Treg IFNg/IL-10 subpopulations 0.85
Hepatic transcriptome of pediatric hepatoblastoma. 0.81
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 0.81
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.79
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.76
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.73
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.72
Gene expression analysis of human adenomas. 0.7
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.68
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.62
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.57
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.57
Leucegene: ALL sequencing 0.56
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 0.53
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 0.48
Human Tfh cell RNA bulk sequencing 0.42
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.38
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.31
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.29
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.29
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.26
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.25
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.22
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.15
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 0.13
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.13
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.11
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.1
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.06
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.04
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.04
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03
Modulation of nonsense-mediated decay by rapamycin 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation